Validation of a treatment-selection rule for patients with advanced stage ovarian cancer

Autor: D E Werter, Marianne J. Rutten, E. van Werkhoven, Marrije R. Buist, C. A. R. Lok, G.G. Kenter, Parvin Tajik, R. van de Vrie, Aeilko H. Zwinderman, J D Asseler, P.M.M. Bossuyt, H. S. van Meurs

Publikováno v: European Journal of Gynaecological Oncology, 41(6), 1023-1030. S.O.G. CANADA Inc.
European journal of gynaecological oncology, 41(6), 1023-1030. S.O.G. CANADA Inc.
van de Vrie, R, van Werkhoven, E, Rutten, M J, Asseler, J D, van Meurs, H S, Werter, D E, Buist, M R, Zwinderman, A H, Lok, C A R, Bossuyt, P M M, Kenter, G G & Tajik, P 2020, ' Validation of a treatment-selection rule for patients with advanced stage ovarian cancer ', European Journal of Gynaecological Oncology, vol. 41, no. 6, pp. 1023-1030 . https://doi.org/10.31083/J.EJGO.2020.06.5369

Purpose of investigation: To externally validate the rule of Van Meurs et al. for selecting patients with advanced epithelial ovarian cancer for treatment with primary surgery or neoadjuvant chemotherapy (NACT). Materials and Methods: We analysed a h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe629493c28ce96ed870500db24eab3d
https://research.vumc.nl/en/publications/dd520116-0709-46a5-bede-c63d5deaeb57